Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Novel antithrombotic therapy

¹Division of Hematology and Oncology, University of Utah School of Medicine, Salt Lake City.

The Western Journal of Medicine

|December 1, 1993

Summary

This summary is machine-generated.

Novel antithrombotic agents show promise for improved and safer therapies. Ongoing basic and clinical investigations are exploring new avenues in antithrombotic drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of a new commercial method for von Willebrand factor multimeric analysis.

International journal of laboratory hematology·2018

Same author

Implementation of a recombinant factor IX Fc fusion protein extended-infusion desensitization protocol.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Same author

A high-performance liquid chromatography method for the serotonin release assay is equivalent to the radioactive method.

International journal of laboratory hematology·2015

Same author

A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).

Journal of thrombosis and haemostasis : JTH·2015

Same author

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: comment.

Journal of thrombosis and haemostasis : JTH·2015

Same author

Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Same journal

Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

The Western journal of medicine·2008

Same journal

[Not Available].

The Western journal of medicine·2008

Same journal

[Not Available].

The Western journal of medicine·2008

Same journal

[Not Available].

The Western journal of medicine·2008

Same journal

[Not Available].

The Western journal of medicine·2008

Same journal

[Not Available].

The Western journal of medicine·2008

See all related articles

Area of Science:

Pharmacology
Cardiovascular Medicine
Drug Discovery

Background:

Thrombotic disorders remain a significant clinical challenge.
Current antithrombotic therapies have limitations regarding efficacy and safety.
There is a continuous need for novel antithrombotic agents.

Purpose of the Study:

To review emerging antithrombotic agents.
To highlight promising novel antithrombotic drugs in development.
To discuss the potential of new therapies for thrombotic conditions.

Main Methods:

Review of current scientific literature.
Analysis of ongoing basic and clinical investigations.
Synthesis of data on novel antithrombotic agents.

Related Experiment Videos

Main Results:

Several novel antithrombotic agents are under investigation.
These agents show potential for enhanced efficacy and safety profiles.
The field of antithrombotic therapy is advancing rapidly.

Conclusions:

The development of new antithrombotic drugs is progressing well.
Future antithrombotic therapies are expected to be more effective and safer.
Further research is crucial to translate these findings into clinical practice.